Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1159]

Emerging targets for the treatment of lung cancer

Prof Tarek Mekhail - Florida Hospital Cancer Institute, Orlando, USA

Emerging targets for the treatment of lung cancer ( Prof Tarek Mekhail - Florida Hospital Cancer Institute, Orlando, USA )

Identifying rare mutations in lung cancer

Dr Raymond Osarogiagbon - Baptist Cancer Center, Memphis, Tennessee, USA

Identifying rare mutations in lung cancer ( Dr Raymond Osarogiagbon - Baptist Cancer Center, Memphis, Tennessee, USA )

The challenge of approving add-on therapies for patients with metastatic cancer

Dr David Montgomery, Alexander Smith

The challenge of approving add-on therapies for patients with metastatic cancer ( Dr David Montgomery, Alexander Smith )

Molecular medicine in lung cancer

Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany

Molecular medicine in lung cancer ( Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany )

Current and future immune approaches in precision medicine

Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France

Current and future immune approaches in precision medicine ( Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France )

Incorporating liquid biopsies into clinical trials

Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor...

Incorporating liquid biopsies into clinical trials ( Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor, USA )

Bayesian adaptive trial designs for precision medicine

Dr Jack Lee - MD Anderson Cancer Center, Houston, USA

Bayesian adaptive trial designs for precision medicine ( Dr Jack Lee - MD Anderson Cancer Center, Houston, USA )

Redesigning clinical trials in the era of precision medicine

Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA

Redesigning clinical trials in the era of precision medicine ( Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA )

Genomic-driven clinical studies in breast cancer

Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA

Genomic-driven clinical studies in breast cancer ( Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )

Synthetic lethality as a basis to select drug combinations

Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland

Synthetic lethality as a basis to select drug combinations ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland )

Patient-specific peptide vaccines

Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany

Patient-specific peptide vaccines ( Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany )

Novel models to personalise cancer therapeutics

Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden

Novel models to personalise cancer therapeutics ( Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden )

More from ecancer